Department of Ophthalmology, Osaka University Medical School, 2-2 Yamada-oka, Suita, Osaka, 565-0871, Japan.
Graefes Arch Clin Exp Ophthalmol. 2011 Dec;249(12):1847-54. doi: 10.1007/s00417-011-1780-z. Epub 2011 Aug 18.
Although it is known that antioxidants including lutein can affect macular pigment optical density (MPOD) and visual function, we still have much to learn about their effect. Our aim was to assess the 1-year changes in MPOD and visual function in response to supplementation containing lutein.
We prospectively measured the MPOD level of those who received a supplement containing 6 mg of lutein daily for 1 year. MPOD level was measured every 3 months by using autofluorescence spectrometry with the two-wavelength method. Other examinations, including contrast sensitivity and retinal sensitivity were also measured every 3 or 6 months. Stepwise regression analysis was performed to determine the factors that correlated with the changes observed in those examinations.
Forty-three eyes of 43 Japanese subjects, including five normal eyes, five fellow eyes with central serous chorioretinopathy (CSC), and 33 fellow eyes with age-related macular degeneration (AMD) were enrolled. The higher baseline MPOD level was correlated with the eye with a clear intraocular lens (IOL). Although no time-dependent changes in the MPOD level were obtained in any area, subjects without cardiovascular diseases showed higher increase in the MPOD level. We observed significant increases in the contrast sensitivity at 1 year (p = 0.0124) and in the retinal sensitivity at 6 months (p < 0.0001) and 1 year (p < 0.0001). Stepwise regression analysis showed that nonsmokers had increased contrast sensitivity (p = 0.0173), and the fellow eye of those with CSC had less of an increase in retinal sensitivity (p = 0.0491).
Daily supplementation with 6 mg of lutein did not affect the MPOD level for 1 year, suggesting that 6 mg of lutein may be insufficient to increase the MPOD level. However, supplementation seems to improve visual functions such as contrast sensitivity and retinal sensitivity.
尽管已知抗氧化剂(包括叶黄素)可以影响黄斑色素光学密度(MPOD)和视觉功能,但我们仍有很多需要了解。我们的目的是评估补充叶黄素后 1 年内 MPOD 和视觉功能的变化。
我们前瞻性地测量了接受含有 6 毫克叶黄素的补充剂治疗 1 年的患者的 MPOD 水平。使用双波长法的自动荧光光谱法每 3 个月测量一次 MPOD 水平。其他检查,包括对比敏感度和视网膜敏感度,也每 3 或 6 个月测量一次。进行逐步回归分析,以确定与这些检查中观察到的变化相关的因素。
43 名日本受试者的 43 只眼,包括 5 只正常眼、5 只伴中心性浆液性脉络膜视网膜病变(CSC)的对侧眼和 33 只伴年龄相关性黄斑变性(AMD)的对侧眼,入组。较高的基线 MPOD 水平与透明晶状体眼有关。尽管在任何区域都未观察到 MPOD 水平的时间依赖性变化,但无心血管疾病的受试者 MPOD 水平升高幅度较高。我们观察到 1 年后(p=0.0124)和 6 个月(p<0.0001)和 1 年后(p<0.0001)对比敏感度显著增加。逐步回归分析显示,不吸烟者的对比敏感度增加(p=0.0173),CSC 对侧眼的视网膜敏感度增加较少(p=0.0491)。
每天补充 6 毫克叶黄素 1 年不会影响 MPOD 水平,表明 6 毫克叶黄素可能不足以增加 MPOD 水平。然而,补充剂似乎可以改善对比敏感度和视网膜敏感度等视觉功能。